Global mRNA Transcriptome Sequencing Market Research Report 2023

Publication ID:

PB503233696

Publication Date:

March 27, 2023

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.
Transcriptome sequencing, or RNA sequencing (RNA-Seq), provides fundamental insights into how genomes are organized and regulated鈥攇iving us valuable information about the internal state of cells and how altered expression of genetic variants contributes to complex disease research.
The global mRNA Transcriptome Sequencing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for mRNA Transcriptome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for mRNA Transcriptome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for mRNA Transcriptome Sequencing in Biomedical Field is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of mRNA Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific and Azenta, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Transcriptome Sequencing.
The mRNA Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Transcriptome Sequencing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Transcriptome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Tech Solutions
Zhijiang Biology
Novogene Co.
Macrogen
Tsingke Biotechnology
Segment by Type
Next Generation Sequencing
Single Molecule Sequencing
Others
Segment by Application
Biomedical Field
Non-medical Field
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Transcriptome Sequencing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Transcriptome Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Next Generation Sequencing
1.2.3 Single Molecule Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global mRNA Transcriptome Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Transcriptome Sequencing Market Perspective (2018-2029)
2.2 mRNA Transcriptome Sequencing Growth Trends by Region
2.2.1 Global mRNA Transcriptome Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Transcriptome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 mRNA Transcriptome Sequencing Forecasted Market Size by Region (2024-2029)
2.3 mRNA Transcriptome Sequencing Market Dynamics
2.3.1 mRNA Transcriptome Sequencing Industry Trends
2.3.2 mRNA Transcriptome Sequencing Market Drivers
2.3.3 mRNA Transcriptome Sequencing Market Challenges
2.3.4 mRNA Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Transcriptome Sequencing Players by Revenue
3.1.1 Global Top mRNA Transcriptome Sequencing Players by Revenue (2018-2023)
3.1.2 Global mRNA Transcriptome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Transcriptome Sequencing Revenue
3.4 Global mRNA Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global mRNA Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Transcriptome Sequencing Revenue in 2022
3.5 mRNA Transcriptome Sequencing Key Players Head office and Area Served
3.6 Key Players mRNA Transcriptome Sequencing Product Solution and Service
3.7 Date of Enter into mRNA Transcriptome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Transcriptome Sequencing Breakdown Data by Type
4.1 Global mRNA Transcriptome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global mRNA Transcriptome Sequencing Forecasted Market Size by Type (2024-2029)
5 mRNA Transcriptome Sequencing Breakdown Data by Application
5.1 Global mRNA Transcriptome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global mRNA Transcriptome Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America mRNA Transcriptome Sequencing Market Size (2018-2029)
6.2 North America mRNA Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America mRNA Transcriptome Sequencing Market Size by Country (2018-2023)
6.4 North America mRNA Transcriptome Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Transcriptome Sequencing Market Size (2018-2029)
7.2 Europe mRNA Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe mRNA Transcriptome Sequencing Market Size by Country (2018-2023)
7.4 Europe mRNA Transcriptome Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Transcriptome Sequencing Market Size (2018-2029)
8.2 Asia-Pacific mRNA Transcriptome Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific mRNA Transcriptome Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Transcriptome Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Transcriptome Sequencing Market Size (2018-2029)
9.2 Latin America mRNA Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America mRNA Transcriptome Sequencing Market Size by Country (2018-2023)
9.4 Latin America mRNA Transcriptome Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Transcriptome Sequencing Market Size (2018-2029)
10.2 Middle East & Africa mRNA Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa mRNA Transcriptome Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Transcriptome Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina mRNA Transcriptome Sequencing Introduction
11.1.4 Illumina Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific mRNA Transcriptome Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad mRNA Transcriptome Sequencing Introduction
11.3.4 Bio-Rad Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.3.5 Bio-Rad Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies mRNA Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN mRNA Transcriptome Sequencing Introduction
11.5.4 QIAGEN Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.5.5 QIAGEN Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche mRNA Transcriptome Sequencing Introduction
11.6.4 Roche Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Detail
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences mRNA Transcriptome Sequencing Introduction
11.7.4 Pacific Biosciences Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.7.5 Pacific Biosciences Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific mRNA Transcriptome Sequencing Introduction
11.8.4 Eurofins Scientific Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.8.5 Eurofins Scientific Recent Development
11.9 Azenta
11.9.1 Azenta Company Detail
11.9.2 Azenta Business Overview
11.9.3 Azenta mRNA Transcriptome Sequencing Introduction
11.9.4 Azenta Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.9.5 Azenta Recent Development
11.10 LabCorp
11.10.1 LabCorp Company Detail
11.10.2 LabCorp Business Overview
11.10.3 LabCorp mRNA Transcriptome Sequencing Introduction
11.10.4 LabCorp Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.10.5 LabCorp Recent Development
11.11 BGI Tech Solutions
11.11.1 BGI Tech Solutions Company Detail
11.11.2 BGI Tech Solutions Business Overview
11.11.3 BGI Tech Solutions mRNA Transcriptome Sequencing Introduction
11.11.4 BGI Tech Solutions Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.11.5 BGI Tech Solutions Recent Development
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Company Detail
11.12.2 Zhijiang Biology Business Overview
11.12.3 Zhijiang Biology mRNA Transcriptome Sequencing Introduction
11.12.4 Zhijiang Biology Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.12.5 Zhijiang Biology Recent Development
11.13 Novogene Co.
11.13.1 Novogene Co. Company Detail
11.13.2 Novogene Co. Business Overview
11.13.3 Novogene Co. mRNA Transcriptome Sequencing Introduction
11.13.4 Novogene Co. Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.13.5 Novogene Co. Recent Development
11.14 Macrogen
11.14.1 Macrogen Company Detail
11.14.2 Macrogen Business Overview
11.14.3 Macrogen mRNA Transcriptome Sequencing Introduction
11.14.4 Macrogen Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.14.5 Macrogen Recent Development
11.15 Tsingke Biotechnology
11.15.1 Tsingke Biotechnology Company Detail
11.15.2 Tsingke Biotechnology Business Overview
11.15.3 Tsingke Biotechnology mRNA Transcriptome Sequencing Introduction
11.15.4 Tsingke Biotechnology Revenue in mRNA Transcriptome Sequencing Business (2018-2023)
11.15.5 Tsingke Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Tech Solutions
Zhijiang Biology
Novogene Co.
Macrogen
Tsingke Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂